Assessing biosimilars in the real world setting

Practical guidance on the assessment of biosimilar monoclonal antibodies: A pharmacist's perspective

Effective communication about biosimilars

The role of the pharmacist in supporting multi-disciplinary education

Realising the potential of biosimilars

Comment: Immunogenicity of biosimilars

Comment: Critical quality attributes of biosimilars

Comment: Use of biosimilar monoclonal antibodies in the clinic

Comment: Supporting a sustainable biosimilar solution

Practical considerations for introducing biosimilars

Successful implementation of biosimilars through effective communication

How real-world data generation can assist biosimilar implementation

Regulatory principles for biosimilar medicines

Biologics utilisation and its efficiency through a hospital pharmacy centralised management system

The science of biosimilarity: Immunogenicity

Introduction of the biosimilar trastuzumab and its impact on patients and services

Practical guidance on the assessment of biosimilar monoclonal antibodies: A physician's perspective